Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder

Simeon D Kimmel1, Sophie Rosenmoss2, Benjamin Bearnot3

  • 1Simeon D. Kimmel (Simeon.Kimmel@bmc.org), Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.

Insights

Patients with opioid use disorder (OUD) face higher rejection rates when referred to postacute care facilities. This study found individuals with OUD experienced significantly more rejections, highlighting access disparities.

Area of Science:

  • Health Services Research
  • Addiction Medicine
  • Health Equity

Background:

  • Hospitalized patients with opioid use disorder (OUD) frequently encounter difficulties accessing postacute medical care.
  • Referrals to postacute care facilities are often rejected for patients with OUD, posing a barrier to continued treatment and recovery.

Purpose of the Study:

  • To investigate the association between an opioid use disorder (OUD) diagnosis and the rejection rates from postacute medical care.
  • To identify potential disparities in postacute care access for hospitalized patients with OUD.

Main Methods:

  • Utilized electronic referral data from a Boston safety-net hospital in 2018, linked with clinical data.
  • Employed multivariable logistic regression to analyze the relationship between OUD diagnosis and postacute care rejection.
  • Compared referral patterns and acceptance rates between patients with and without OUD.

Main Results:

  • Hospitalized patients with OUD received more referrals per hospitalization (8.2 vs. 6.6) but had a higher rejection proportion (83.3% vs. 65.5%).
  • Adjusted analyses revealed patients with OUD had significantly greater odds of rejection from postacute care (aOR, 2.2).
  • Patients with OUD were disproportionately referred to a limited number of facilities with higher acceptance rates.

Conclusions:

  • Findings demonstrate significant disparities in postacute care admissions for individuals with opioid use disorder (OUD).
  • There is a critical need for interventions to ensure equitable access to medically necessary postacute care for people with OUD.
  • Addressing these access barriers is crucial for improving continuity of care and recovery outcomes for OUD patients.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
868
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
473
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
790
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.2K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
879
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
416